MLSS Milestone Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MLSS

Price (delayed)

$0.4808

Market cap

$42.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$41.21M

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 81
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 30

Milestone Scientific Inc. (Milestone) is engaged in computer-controlled injection technologies and solutions for the medical and dental markets. Milestone has developed a computer-controlled anesthetic delivery instrument, through the use of ...

Highlights
The company's quick ratio has surged by 97% QoQ and by 37% YoY
Milestone Scientific's EPS has soared by 56% YoY and by 20% from the previous quarter
The company's gross margin fell by 3.6% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.milestonescientific.com
Peers: APT XRAY ALGN

Key stats

What are the main financial stats of MLSS

MLSS stock price

How has the Milestone Scientific stock price performed over time
Intraday
2.23%
1 week
-2.89%
1 month
16.7%
1 year
-19.04%
YTD
76.12%
QTD
49.78%

Financial performance

How have Milestone Scientific's revenue and profit performed over time
Revenue
$9.42M
Gross profit
$6.62M
Operating income
-$4.1M
Net income
-$4.14M
Gross margin
70.2%
Net margin
-44%
The operating margin has increased by 43% year-on-year and by 14% since the previous quarter
The net margin has grown by 43% YoY and by 14% from the previous quarter
The net income has grown by 41% year-on-year and by 9% since the previous quarter
MLSS's operating income is up by 41% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does MLSS's price correlate with its fundamentals

Growth

What is Milestone Scientific's growth rate over time

Valuation

What is Milestone Scientific stock price valuation
P/E
N/A
P/B
12.2
P/S
4.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.37
Milestone Scientific's EPS has soared by 56% YoY and by 20% from the previous quarter
The equity has soared by 52% from the previous quarter and by 3.9% YoY
The P/B is 42% higher than the 5-year quarterly average of 8.6 and 23% higher than the last 4 quarters average of 9.9
The P/S is 53% more than the last 4 quarters average of 3.1 but 30% less than the 5-year quarterly average of 6.8
The revenue is up by 6% since the previous quarter and by 3.7% year-on-year

Efficiency

How efficient is Milestone Scientific business performance
Milestone Scientific's ROS has increased by 43% YoY and by 14% from the previous quarter
The company's return on invested capital rose by 39% YoY but it fell by 2.3% QoQ
MLSS's ROA is up by 31% YoY and by 10% QoQ
The return on equity has declined by 11% year-on-year but it has increased by 10% since the previous quarter

Dividends

What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MLSS.

Financial health

How did Milestone Scientific financials performed over time
The total assets is 71% greater than the total liabilities
The company's quick ratio has surged by 97% QoQ and by 37% YoY
Milestone Scientific's current ratio has increased by 23% from the previous quarter but it has decreased by 9% YoY
The debt is 82% less than the equity
Milestone Scientific's debt to equity has plunged by 58% from the previous quarter and by 45% YoY
The equity has soared by 52% from the previous quarter and by 3.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.